KKR has acquired Medicover, a Sweden-based international healthcare and diagnostic services provider listed on Nasdaq Stockholm, for an undisclosed amount. The transaction takes the company private, ending its public listing following a period of sustained growth across its European and Asian markets.
Medicover, founded in 1995 in Poland, operates in 19 countries with more than 48,000 employees. Its largest markets include Poland, Germany, Romania, India, and Ukraine. The company runs two divisions: Healthcare Services, which covers outpatient clinics, hospitals, fertility treatment, dental care, and wellbeing programs, and Diagnostic Services, which provides clinical laboratory testing across major pathology areas. Its network spans hospitals, specialty-care facilities, and blood-drawing points.
For KKR, the acquisition aligns with its broader focus on essential services with long-term structural demand. Healthcare provision in Central and Eastern Europe and India has grown steadily, driven by aging populations and rising private spending on medical care. Medicover’s integrated model, combining care delivery with diagnostics, offers a platform that can expand within existing markets and enter adjacent ones. KKR’s capital and operational expertise are expected to support investments in digital infrastructure and facility expansion.
The deal also provides Medicover with greater flexibility to pursue longer-term projects without quarterly reporting constraints. Management continuity is expected, with existing leadership remaining in place to execute the company’s growth strategy. The acquisition is subject to customary regulatory approvals and is expected to close in the coming months.
Once completed, the combined entity will operate as a privately held healthcare group with a strong footprint in high-growth regions. KKR’s backing is likely to accelerate Medicover’s clinic network development and diagnostic capacity, particularly in markets where healthcare access remains uneven. The company’s established brand and operational scale position it to capture further demand for preventive and specialized care across its 19-country footprint.